Overview

Comparative and Efficacy Study of ACTHar Gel Alone or in Combination With Tacrolimus in Fibrillary Glomerulopathy

Status:
Recruiting
Trial end date:
2022-03-14
Target enrollment:
Participant gender:
Summary
Treatment with combination ACTHar gel and Tacrolimus therapy or ACTHar gel therapy alone in lowering urinary protein to creatinine (UP/Cr) ratios
Phase:
Phase 4
Details
Lead Sponsor:
NephroNet, Inc.
Collaborator:
Mallinckrodt
Treatments:
Adrenocorticotropic Hormone
Tacrolimus